Biogen’s Adam Keeney Focuses On Dealmaking As Growth Strategy Is Made Over

Biogen, Inc.’s new president and CEO Christopher Viehbacher has brought in former Sanofi colleague Adam Keeney to help advance the company’s goal of “sustainable growth” from its existing products and programs as well as from assets sourced externally. Keeney, Biogen’s newly appointed executive vice president and head of corporate development, told Scrip he is encouraged by what the company already is working on and is looking forward to bringing novel therapies into the mix.

But to say that Biogen’s current growth trajectory is in need of a turnaround may be an understatement. The company...